<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039699</url>
  </required_header>
  <id_info>
    <org_study_id>MMH-ER-008</org_study_id>
    <nct_id>NCT03039699</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children</brief_title>
  <official_title>International Multicenter, Double-blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Materia Medica Holding</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Materia Medica Holding</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain additional data on efficacy and safety of Ergoferon in
      the treatment of viral intestinal infections in inpatient children
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 23, 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average diarrhea duration</measure>
    <time_frame>From the time of randomization until the time of normal stool (normal consistency and normal frequency), assessed up to 14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients without diarrhea</measure>
    <time_frame>Study entry, 48, 72, and 96 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with recovery</measure>
    <time_frame>Study entry, 48, 72, and 96 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average illness duration</measure>
    <time_frame>From the time of randomization until the time of alleviation of all symptoms, assessed up to 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total CDS score</measure>
    <time_frame>Study entry, 24, 48, and 72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average vomiting duration</measure>
    <time_frame>From the time of randomization until the time of vomiting absence, assessed up to 14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with negative PCR tests</measure>
    <time_frame>Study entry, 3, 4, 5, and 10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with worsening of illness and/or hospital-acquired infection</measure>
    <time_frame>From the time of randomization up to 14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">286</enrollment>
  <condition>Viral Intestinal Infection</condition>
  <arm_group>
    <arm_group_label>Ergoferon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 tablet 3 times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 tablet 3 times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergoferon</intervention_name>
    <arm_group_label>Ergoferon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients of both sexes aged from 6 months to 6 years, who have been admitted to
             hospital infectious diseases unit.

          2. Diarrhea (watery diarrhea at least 3 times a day).

          3. CDS score of ≥1.

          4. The first 48 hours from the onset of the first diarrhea episode.

          5. Start of study treatment (Ergoferon/Placebo) within 12 hours after the start of the
             standard hospital therapy.

          6. Availability of a patient information sheet (Informed Consent form) signed by the
             patient's parents/adopters to confirm the child's participation in the clinical trial
             signed by one parent/adopter of patient.

        Exclusion Criteria:

          1. Suspected bacterial intestinal infection.

          2. Suspected infectious diseases affecting other organ systems (e.g. pneumonia,
             meningitis, sepsis, otitis media, urinary tract infection, etc.).

          3. Severe intestinal infection .

          4. Severe dehydration (CDS score ≥7).

          5. Anuria (acute kidney injury).

          6. Medical history or prior diagnosis of serious diseases, including primary/secondary
             immunodeficient, oncological disease, diabetes mellitus, infantile cerebral palsy,
             mucoviscidosis/cystic fibrosis etc.

          7. Exacerbation or decompensation of a chronic disease, including diseases of the
             digestive system that would affect the patient's ability to participate in the
             clinical trial.

          8. Malabsorption syndrome, including congenital or acquired lactose intolerance/lactase
             deficiency or any other disaccharidase deficiency and galactosemia.

          9. Allergy/ intolerance to any of the components of medications used in the treatment.

         10. Course intake of medicines listed in the section &quot;Prohibited concomitant treatment&quot;
             for 2 weeks prior to the enrollment in the trial.

         11. Participation in other clinical trials within 3 months prior to the enrollment in this
             study.

         12. Patients whose parents/adopters, from investigator's point of view, will fail to
             comply with the observation requirements of the trial or with the dosing regimen of
             the study drugs.

         13. Patient's parents/adopters are related to the research staff of the clinical
             investigative site who are directly involved in the trial or are the immediate family
             member of the researcher. The immediate family members include husband/wife, parents,
             children or brothers (or sisters), regardless of whether they are natural or adopted.

         14. The patient's parent/adopter works for OOO &quot;NPF &quot;MATERIA MEDICA HOLDING&quot; (i.e., is the
             company's employee, temporary contract worker or appointed official responsible for
             carrying out the research) or the immediate relative.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mikhail Putilovskiy, MD</last_name>
    <phone>+74952761571</phone>
    <phone_ext>302</phone_ext>
    <email>PutilovskiyMA@materiamedica.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>State budgetary health care institution of the Arkhangelsk region &quot;Arkhangelsk Regional Pediatric Clinical Hospital named after PG Vyzhletsova&quot;</name>
      <address>
        <city>Arkhangel'sk</city>
        <zip>163002</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Samodova, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Olga Samodova, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Institution of Higher Professional Education &quot;Urals State Medical University&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Ekaterinburg</city>
        <zip>620028</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Educational Institution of Higher Education &quot;Kazan Medical University&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Kazan'</city>
        <zip>420012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Anokhin, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Vladimir Anokhin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal Budget Institution of Science &quot;Central Research Institute of Epidemiology&quot; of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance</name>
      <address>
        <city>Moscow</city>
        <zip>111123</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksandr Gorelov, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Aleksandr Gorelov, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pirogov Russian National Research Medical University</name>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nadezhda Zvereva, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Nadezhda Zvereva, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Educational Institution of Higher Education &quot;Orenburg State Medical University&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Orenburg</city>
        <zip>460000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viktor Pruss, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Viktor Pruss, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Municipal Budgetary Health Care Institutions &quot;Semashko City Hospital №1 Rostov-on-Don &quot;</name>
      <address>
        <city>Rostov-on-Don</city>
        <zip>344000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Educational Institution of Higher Education &quot;Saint Petersburg State Pediatric Medical University&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>194100</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vladimir Timchenko, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Vladimir Timchenko, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sailnt Petersburg State Budgetary Health Care Institution &quot;City Child Hospital №22&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>196657</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Koshchavceva, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marina Koshchavceva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal State Institution &quot;Scientific Research Institute of Children's Infections Federal Biomedical Agency&quot;</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197022</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurij Lobzin, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Yurij Lobzin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The State Budget Educational institution of High Professional Training Smolensk State Medical University of Ministry of Health Care of the Russian Federation</name>
      <address>
        <city>Smolensk</city>
        <zip>214018</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonina Grekova, MD</last_name>
    </contact>
    <investigator>
      <last_name>Antonina Grekova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Federal State Budgetary Educational Institutionof Higher Education &quot;Yaroslavl State Medical University&quot; of the Ministry of Healthcare of the Russian Federation</name>
      <address>
        <city>Yaroslavl</city>
        <zip>150000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Sitnikov, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Ivan Sitnikov, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scientific Research Institute of Virology of Ministry of Health of Republic Uzbekistan</name>
      <address>
        <city>Tashkent</city>
        <zip>100194</zip>
        <country>Uzbekistan</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
    <country>Uzbekistan</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Trematode Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

